Drugs / GlcNAc-GlcN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05402345 | Jan 2025 → Dec 2026 expected | congenital disorder of deglycosylation | Eva Morava-Kozicz | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GlcNAc-GlcN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05402345 ↗ |